Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day. The study finds that this so-called 'wonder drug' may be less effective in patients resistant to older drugs.
from Latest Science News -- ScienceDaily https://ift.tt/2Vn3Ean
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment